Production of Trichophyton rubrum microspores in large quantities and its application to evaluate amorolfine/azole compound interactions in vitro

Trichophyton rubrum is the most frequently isolated dermatophyte species in European countries. The lack or poor sporulation of T. rubrum has always been a major complication and a limiting factor when performing antifungal susceptibility testing. Therefore, we describe an in vitro method aiming to enhance sporulation of various T. rubrum isolates in order to perform antifungigrams. A combination of high CO2 tensions and incubation on PDA growth medium revealed to be optimal for sporulation of all tested T. rubrum isolates. This method was further used to examine in vitro the combined effects of amorolfine and azole derivatives against fungal growth using adapted checkerboard microdilution assays and an isobolographic approach of the data, adapted disc diffusion and Etest assays. Non‐antagonistic and synergistic effects were observed in these settings with amorolfine combined to each of the tested azole compounds. The optimised culture method appeared to be suitable for T. rubrum isolates for which antifungigrams were especially difficult to obtain because of the lack of sporulation.

[1]  H. Badali,et al.  In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates. , 2016, Medical mycology.

[2]  H. Badali,et al.  In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs , 2015, Mycoses.

[3]  K. Makimura,et al.  In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes , 2014, Microbiology and immunology.

[4]  O. Jousson,et al.  The dermatophyte species Arthroderma benhamiae: intraspecies variability and mating behaviour. , 2013, Journal of medical microbiology.

[5]  R. Tallarida,et al.  Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism , 2012, Journal of Pharmacology and Experimental Therapeutics.

[6]  Archana D. Thakre,et al.  Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle. , 2011, Phytomedicine.

[7]  Seungwon Shin,et al.  Combinatorial anti-Trichophyton effects of Ligusticum chuanxiong essential oil components with antibiotics , 2008, Archives of pharmacal research.

[8]  T. Walsh,et al.  Isobolographic Analysis of Pharmacodynamic Interactions between Antifungal Agents and Ciprofloxacin against Candida albicans and Aspergillus fumigatus , 2008, Antimicrobial Agents and Chemotherapy.

[9]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[10]  Carolina Johansson,et al.  A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[11]  P. Verweij,et al.  The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions. , 2006, International journal of antimicrobial agents.

[12]  S. Shin,et al.  Antifungal effects of the volatile oils from Allium plants against Trichophyton species and synergism of the oils with ketoconazole. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[13]  N. Gow,et al.  Antifungal agents: mechanisms of action. , 2003, Trends in microbiology.

[14]  O. Jousson,et al.  Identification of Dermatophyte Species by 28S Ribosomal DNA Sequencing with a Commercial Kit , 2003, Journal of Clinical Microbiology.

[15]  M. Monod,et al.  Survey of Dermatophyte Infections in the Lausanne Area (Switzerland) , 2002, Dermatology.

[16]  M. Lecha.  Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain , 2001, The British journal of dermatology.

[17]  R. Baran.  Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost‐effective treatment for onychomycosis , 2001, The British journal of dermatology.

[18]  J. Czernielewski,et al.  A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region , 2000, The British journal of dermatology.

[19]  M. Ghannoum,et al.  Antifungal Susceptibility Testing of Dermatophytes: Establishing a Medium for Inducing Conidial Growth and Evaluation of Susceptibility of Clinical Isolates , 2000, Journal of Clinical Microbiology.

[20]  D S Burgess,et al.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test , 1996, Antimicrobial agents and chemotherapy.

[21]  A. Polak.  Mode of Action of Morpholine Derivatives , 1988, Annals of the New York Academy of Sciences.

[22]  S. Knight,et al.  Growth of Trichophyton mentagrophytes and Trichophyton rubrum in increased carbon dioxide tensions. , 1957, Journal of General Microbiology.